Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Shenzhen

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

8

Recruiting now

12

Active studies

Recruiting Phase 3

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis
Bristol-Myers Squibb · started 2025-12-03

📍 Beijing · Guangzhou · Shenzhen · Handan · Zhengzhou · Changsha

NCT06979453 on ClinicalTrials.gov ↗

Recruiting Phase 2

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc. · started 2025-11-26

📍 Baotou · Beijing · Guangzhou · Hangzhou · Nanchang · Shenzhen

NCT07160608 on ClinicalTrials.gov ↗

Recruiting Phase 3

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Plaque Psoriasis
Bristol-Myers Squibb · started 2025-09-22

📍 Bengbu · Beijing · Chongqing · Fuzhou · Guangzhou · Shenzhen

NCT07116967 on ClinicalTrials.gov ↗

Recruiting

Real World Evidence Study of SYN023 in Children Exposed to Rabies

Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. · started 2025-08-02

📍 Beijing · Shenzhen · Changsha · Hengyang · Nanchang

NCT07327307 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Multi-CAR T Cell Therapy for Acute Myeloid Leukemia

Acute Myeloid Leukemia
Shenzhen Geno-Immune Medical Institute · started 2025-07-15

📍 Shenzhen

NCT03222674 on ClinicalTrials.gov ↗

Recruiting

Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial

Hypertension
China National Center for Cardiovascular Diseases · started 2025-05-26

📍 Shenzhen

NCT06828692 on ClinicalTrials.gov ↗

Recruiting Phase 3

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart Failure, Heart Failure With Reduced Ejection Fraction
Cytokinetics · started 2024-12-19

📍 Beijing · Lanzhou · Guangzhou · Shenzhen · Luoyang · Changsha

NCT06736574 on ClinicalTrials.gov ↗

Recruiting

Long-term Follow-up Study of BRL-101 for TDT

Thalassemia, Beta
Bioray Laboratories · started 2024-12-08

📍 Guangzhou · Shenzhen · Nanning · Changsha · Tianjin · Guangxi

NCT06298630 on ClinicalTrials.gov ↗

Active

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Diabetic Macular Edema
AbbVie · started 2023-10-30

📍 Shenzhen · Wuhan · Xi'an · Qingdao · Chengdu

NCT05978622 on ClinicalTrials.gov ↗

Active

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals · started 2022-09-12

📍 Shenzhen

NCT05399992 on ClinicalTrials.gov ↗

Active Phase 1

Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies

Mature B-cell Malignancies
BeiGene · started 2021-07-05

📍 Beijing · Guangzhou · Shenzhen · Zhengzhou · Wuhan · Changsha

NCT04883957 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)

Takayasu Arteritis (TAK)
AbbVie · started 2020-02-04

📍 Beijing · Guangzhou · Shenzhen · Shenyang · Shanghai

NCT04161898 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2

Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/shenzhen (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.